It is very uncertain whether mesalazine changes clinical response compared with mesalazine + cholestyramine (very low certainty).
Mesalazine showed no clear difference in clinical response compared with mesalazine + cholestyramine (low certainty).
Budesonide may leads to higher clinical response compared with mesalazine (low certainty).
Budesonide may leads to higher clinical response compared with mesalazine (low certainty).
Beclometasone dipropionate showed no clear difference in clinical response at 8 weeks compared with mesalazine (low certainty).
It is very uncertain whether beclometasone dipropionate changes maintenance of clinical response at 12 weeks compared with mesalazine (very low certainty).